Elan

Elan rejects Royalty bid as grossly undervaluing its prospects
Reuters
Mon, 04/22/13 - 10:24 am
Royalty Pharma
Elan
M&A
Elan buyback priced at $11.25 reduces Royalty bid
Reuters
Thu, 04/18/13 - 10:39 am
Royalty Pharma
Elan
stock buyback
Royalty Pharma sweetens offer for Elan
Reuters
Mon, 04/15/13 - 08:48 am
Elan
M&A
Royalty Pharma
Elan shareholders approve buyback as Royalty fight heats up
Reuters
Fri, 04/12/13 - 01:38 pm
Elan
Royalty Pharma
Elan completes sale of Tysabri stake to Biogen
Reuters
Wed, 04/3/13 - 10:51 am
Tysabri
Elan
Biogen Idec
MS
multiple sclerosis
Elan will start $1B Dutch auction for shares
Yahoo/AP
Sat, 03/9/13 - 11:45 am
Elan
Royalty Pharma Meeting With Elan Investors on Bid
Bloomberg
Wed, 03/6/13 - 09:46 am
Royalty Pharma
Elan
M&A
Elan offers Tysabri dividend, dismisses Royalty offer
Reuters
Mon, 03/4/13 - 10:38 am
Elan
dividends
Tysabri
Royalty Pharma
Royalty Pharma plans to tap Elan investors on offer -source
Reuters
Wed, 02/27/13 - 11:34 am
Elan
investors
M&A
Royalty Pharma
The Fight Over This Biotech's Cash
Motley Fool
Tue, 02/26/13 - 10:13 am
Elan
Royalty Pharma
Royalty Pharma proposes $6.6 bln bid for Elan
Reuters
Mon, 02/25/13 - 10:30 am
M&A
Royalty Pharma
Elan
Elan Armed With Biogen Billions Hunts for Deals: Real M&A
Bloomberg
Mon, 02/25/13 - 10:12 am
Elan
Biogen Idec
M&A
Elan to return $1 billion to shareholders from multiple sclerosis drug sale
Reuters
Fri, 02/22/13 - 10:44 am
Elan
Tysabri
share repurchase
A Strong Growth Opportunity In Multiple Sclerosis
Motley Fool
Wed, 02/20/13 - 11:46 am
multiple sclerosis
MS
Elan
Biogen Idec
Tysabri
Teva
XenoPort
Sanofi
BG-12
U.S. FDA outlines path to test Alzheimer's drugs earlier
Reuters
Fri, 02/8/13 - 11:10 am
FDA
Alzheimer's disease
Eli Lilly
Pfizer
Elan
JNJ
Elan seeks acquisitions after $3.25 bn Biogen Idec deal, rival Bayer eyed on MS treatments
Financial Express
Thu, 02/7/13 - 11:03 am
Elan
Bayer
M&A
Biogen Idec
Tysabri
A Win-Win Multiple Sclerosis Deal?
Motley Fool
Thu, 02/7/13 - 10:10 am
MS
multiple sclerosis
Tysabri
Biogen Idec
Elan
Biogen pays Elan $3.25 billion to take over MS drug
Reuters
Wed, 02/6/13 - 08:25 am
Biogen Idec
Elan
Tysabri
M&A
MS
multiple sclerosis
2013 Should Be Interesting for Multiple Sclerosis Drugs
Motley Fool
Thu, 01/3/13 - 11:39 am
MS
multiple sclerosis
Teva
Copaxone
Rebif
Pfizer
Merck KGaA
Biogen Idec
Avonex
Bayer
Betaseron
Novartis
Extavia
Sanofi
Tysabri
Aubagio
Elan
Gilenya
BG-12
SAC Sued by Elan Investors Over Alleged Insider Trades
Bloomberg
Thu, 01/3/13 - 11:30 am
Elan
SAC
insider trading

Pages